GB1493237A - Pharmaceutical preparations for the treatment of hyperuricacidemia - Google Patents

Pharmaceutical preparations for the treatment of hyperuricacidemia

Info

Publication number
GB1493237A
GB1493237A GB19223/76A GB1922376A GB1493237A GB 1493237 A GB1493237 A GB 1493237A GB 19223/76 A GB19223/76 A GB 19223/76A GB 1922376 A GB1922376 A GB 1922376A GB 1493237 A GB1493237 A GB 1493237A
Authority
GB
United Kingdom
Prior art keywords
hyperuricacidemia
mgs
hydroxy
treatment
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19223/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Publication of GB1493237A publication Critical patent/GB1493237A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB19223/76A 1975-12-10 1976-05-11 Pharmaceutical preparations for the treatment of hyperuricacidemia Expired GB1493237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752555609 DE2555609A1 (de) 1975-12-10 1975-12-10 Pharmazeutisches praeparat zur therapie der hyperurikaemie

Publications (1)

Publication Number Publication Date
GB1493237A true GB1493237A (en) 1977-11-30

Family

ID=5964014

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19223/76A Expired GB1493237A (en) 1975-12-10 1976-05-11 Pharmaceutical preparations for the treatment of hyperuricacidemia

Country Status (8)

Country Link
AU (1) AU505476B2 (fr)
BE (1) BE842389A (fr)
CA (1) CA1048933A (fr)
DE (1) DE2555609A1 (fr)
FR (1) FR2334362A1 (fr)
GB (1) GB1493237A (fr)
NL (1) NL7605531A (fr)
ZA (1) ZA763081B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1698348A1 (fr) * 2003-11-14 2006-09-06 Human Cell Systems, Inc. Remede curatif ou preventif des troubles vasculaires et de l'hypertension et son procede de criblage
US7659424B2 (en) 2004-03-01 2010-02-09 Japan Science And Technology Agency Process for the allylation of n-acylhydrazones
US20100120796A1 (en) * 2004-07-21 2010-05-13 Johnson Richard J Compositions and methods for treatment and prevention of hyperuricemia related health consequneces
CN103242272A (zh) * 2013-05-22 2013-08-14 合肥医工医药有限公司 一种制备苯溴马隆的方法
US20130225673A1 (en) * 2010-10-06 2013-08-29 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1698348A1 (fr) * 2003-11-14 2006-09-06 Human Cell Systems, Inc. Remede curatif ou preventif des troubles vasculaires et de l'hypertension et son procede de criblage
EP1698348A4 (fr) * 2003-11-14 2008-02-27 Human Cell Systems Inc Remede curatif ou preventif des troubles vasculaires et de l'hypertension et son procede de criblage
US8236488B2 (en) 2003-11-14 2012-08-07 Human Cell Systems, Inc. Method of screening for therapeutic compounds for vascular disorders and hypertension based on URAT1 activity modulation
US7659424B2 (en) 2004-03-01 2010-02-09 Japan Science And Technology Agency Process for the allylation of n-acylhydrazones
US20100120796A1 (en) * 2004-07-21 2010-05-13 Johnson Richard J Compositions and methods for treatment and prevention of hyperuricemia related health consequneces
US20130225673A1 (en) * 2010-10-06 2013-08-29 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
US10005750B2 (en) * 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
CN103242272A (zh) * 2013-05-22 2013-08-14 合肥医工医药有限公司 一种制备苯溴马隆的方法

Also Published As

Publication number Publication date
NL7605531A (nl) 1977-06-14
BE842389A (fr) 1976-09-16
ZA763081B (en) 1977-04-27
AU505476B2 (en) 1979-11-22
DE2555609A1 (de) 1977-06-30
AU1541376A (en) 1978-01-05
FR2334362A1 (fr) 1977-07-08
FR2334362B1 (fr) 1979-08-24
CA1048933A (fr) 1979-02-20

Similar Documents

Publication Publication Date Title
JPS5241214A (en) Method of making preparations for oral administration
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
IL60282A (en) Nonapeptide and decapeptide derivatives of lh releasing hormone,their preparation and pharmaceutical compositions containing them
IE43693L (en) Androstane derivatives
DE2962627D1 (en) Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
ES8400076A1 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
IE38302B1 (en) Aromatic hydroxy amines
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
GB1493237A (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
DE2962580D1 (en) 7-phenyl-quinolizidine derivatives (i), their preparation, pharmaceutical compositions containing them and (i) for use in treating diseases
IE791995L (en) Formulation
IE37250L (en) Triazolobenzodiazepines
IE45054L (en) Veterinary composition
IE813057L (en) Thiazoline derivatives
ES8703459A1 (es) Procedimiento para la preparacion de derivados de acido 4- (isoxazolil)-tiazol-2-oxamico
DE2967075D1 (en) Heterocyclic derivatives of guanidine, their preparation and pharmaceutical formulations comprising them
DE2962834D1 (en) 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
ES8308884A1 (es) Procedimiento para la preparacion de nuevas imidazo(1,2-a)pirimidinas.
IE780921L (en) 1-acyl-2-hydroxy-1,3-diamino-propanes.
CY1228A (en) Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use
IE43994L (en) Diphenylmethanes.
EP0056681A3 (fr) Formulations de lévonantradol et N-methyllévonantradol
NL7901103A (nl) 1,1-digesubstitueerde octahydroindool 2,3-a chinoli- zinen, farmaceutisch aanvaardbare zouten daarvan; werk- wijze voor de bereiding van deze verbindingen, farmaceutische preparaten waarin zich deze verbindingen bevinden, met vaatverwijdende eigenschappen.

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee